66 Days
Source:
The Boston Globe
_1777370220974_847775619.png&w=64&q=75){kind=small}
Massachusetts urged to lead in psychedelic medicine
The authors advocate for retaining and expanding a pilot program in Massachusetts that allows controlled, clinical use of psychedelic-assisted therapy for severe depression and end-of-life distress. They emphasize the therapy’s safety and potential effectiveness, supported by ongoing research, and urge the legislation to maintain strict oversight and reporting requirements. The goal is to provide legal pathways for these treatments within Massachusetts, ensuring local access for patients while safeguarding rigorous scientific evaluation.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)